Prevalence and risk factors of meibomian gland dysfunction: the Singapore Malay eye study
- PMID: 22236788
- DOI: 10.1097/ICO.0b013e31823f0977
Prevalence and risk factors of meibomian gland dysfunction: the Singapore Malay eye study
Abstract
Purpose: To describe the prevalence and associations of meibomian gland dysfunction (MGD) in an urban Malay population in Singapore.
Methods: Population-based cross-sectional study of 3280 (78.7% response rate) Malay persons aged 40 to 80 years, living in Singapore. MGD was defined by a slit-lamp clinical examination as either lid margin telangiectasia or meibomian gland orifice plugging in at least one eye. Participants underwent a standardized questionnaire and clinical examination, including laboratory investigations. Data were analyzed for 3271 persons.
Results: The age-standardized prevalence of MGD was 56.3% [95% confidence interval (CI), 53.3-59.4]. A higher MGD prevalence was found in male participants across all age groups [odds ratio (OR), 1.30; 95% CI, 1.35-1.79], postmenopausal women (OR, 1.64; 95% CI, 1.19-2.33), and all participants with pinguecula (OR, 2.43; 95% CI, 2.08-2.85), high diastolic blood pressure (OR, 1.32; 95% CI, 1.08-1.62), and use of angiotensin II receptor blockers (OR, 4.02; 95% CI, 1.74-9.27).
Conclusions: MGD was highly prevalent in this Asian population and associated with various systemic and ocular conditions.
Similar articles
-
Estimation of Prevalence of Meibomian Gland Dysfunction in Japan.Cornea. 2017 Jun;36(6):684-688. doi: 10.1097/ICO.0000000000001208. Cornea. 2017. PMID: 28410360
-
Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain.Invest Ophthalmol Vis Sci. 2012 May 4;53(6):2601-6. doi: 10.1167/iovs.11-9228. Invest Ophthalmol Vis Sci. 2012. PMID: 22427596
-
Meibomian gland dysfunction and its determinants in Iranian adults: A population-based study.Cont Lens Anterior Eye. 2017 Aug;40(4):213-216. doi: 10.1016/j.clae.2017.05.003. Epub 2017 May 10. Cont Lens Anterior Eye. 2017. PMID: 28501443
-
Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction.Cochrane Database Syst Rev. 2020 Mar 18;3(3):CD013559. doi: 10.1002/14651858.CD013559. Cochrane Database Syst Rev. 2020. PMID: 32182637 Free PMC article.
-
Nonobvious obstructive meibomian gland dysfunction.Cornea. 2010 Dec;29(12):1333-45. doi: 10.1097/ICO.0b013e3181d4f366. Cornea. 2010. PMID: 20847669 Review.
Cited by
-
Prevalence of meibomian gland dysfunction in staffs and faculty members of a Chinese university.Int J Ophthalmol. 2020 Oct 18;13(10):1667-1670. doi: 10.18240/ijo.2020.10.23. eCollection 2020. Int J Ophthalmol. 2020. PMID: 33078120 Free PMC article.
-
Noninvasive ocular surface analyzer as an adjunct in diagnosis and estimating prevalence of meibomian gland dysfunction: Hospital-based comparative study.Indian J Ophthalmol. 2022 May;70(5):1539-1545. doi: 10.4103/ijo.IJO_2245_21. Indian J Ophthalmol. 2022. PMID: 35502020 Free PMC article.
-
Update on the role of impression cytology in ocular surface disease.Taiwan J Ophthalmol. 2019 Sep 12;9(3):141-149. doi: 10.4103/tjo.tjo_57_19. eCollection 2019 Jul-Sep. Taiwan J Ophthalmol. 2019. PMID: 31572650 Free PMC article. Review.
-
Factors affecting long-term changes of meibomian gland in MGD patients.Graefes Arch Clin Exp Ophthalmol. 2024 Feb;262(2):527-535. doi: 10.1007/s00417-023-06210-1. Epub 2023 Aug 31. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37650897
-
To Find Out the Relationship Between Levels of Glycosylated Hemoglobin with Meibomian Gland Dysfunction in Patients with Type 2 Diabetes.Ther Clin Risk Manag. 2021 Aug 6;17:797-807. doi: 10.2147/TCRM.S324423. eCollection 2021. Ther Clin Risk Manag. 2021. PMID: 34393486 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical